China Resources Double-Crane Pharmaceutical Co., Ltd.SSE: 600062

(600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtaining the Drug Registration Certificate for Baricitinib Tablets by the Wholly-owned Subsidiary Beijing Wanhui Double-Crane Pharmaceutical Co., Ltd.

· Issued by China Resources Double-Crane Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600062 ·

On 6ix: 6ix.com/news/600062china-resources-double-crane-pharmaceutical-co-ltdannouncement-on-obtaining-the-drug-registration-certificate-for-baricitinib-tablets-by-the-wholly-owned-subsidiary-beijing-wanhui-double-crane-pharmaceutical-co-ltd

Announcement on Obtaining the Drug Registration Certificate for Baricitinib Tablets by the Wholly-owned Subsidiary Beijing Wanhui Double-Crane Pharmaceutical Co., Ltd.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

6ix is reading this filing.

View original source (Shanghai Stock Exchange)China Resources Double-Crane Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from China Resources Double-Crane Pharmaceutical

All China Resources Double-Crane Pharmaceutical news releases